Alpha Tau Medical Ltd.
Price Action
Technical Summary
STAGE 2 UPTRENDAlpha Tau Medical Ltd. is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 97), indicating clear outperformance against the broad market. However, price is extended 37% above the 50-day line, increasing the risk of a mean reversion.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $10.34 | +27.89% | ABOVE |
| 50 SMA | $9.67 | +36.76% | ABOVE |
| 100 SMA | $8.49 | +55.85% | ABOVE |
| 150 SMA | $7.56 | +74.98% | ABOVE |
| 200 SMA | $6.67 | +98.35% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is DRTS in an uptrend right now?
DRTS has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, DRTS is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.
Is DRTS overbought or oversold?
DRTS's RSI (14) is 70. The stock is in overbought territory (RSI > 70), which may signal a pullback.
Is DRTS outperforming the market?
DRTS has a Relative Strength (RS) Rating of 97 out of 99. Yes, DRTS is a market leader, outperforming 97% of all stocks over the past 12 months.
Where is DRTS in its 52-week range?
DRTS is trading at $13.23, which is 100% of its 52-week high ($13.23) and 100% above its 52-week low ($2.87).
How volatile is DRTS?
DRTS has a Beta of 1.95 and 52-week volatility of 76%. It's more volatile than the S&P 500 - expect bigger swings.